Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Czechia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20101
20122
20142
20151
20161
20171
20181
20191
20201
20211
20222
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Active, not recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx4
Novartis Pharmaceuticals3
Amgen2
Chugai Pharmaceutical2
GlaxoSmithKline2
Rigel Pharmaceuticals2
Baxalta now part of Shire1
Biotest1
Bioverativ, a Sanofi company1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic24
Thrombocytopenia3
Antiphospholipid Syndrome2
Behcet Syndrome2
Dermatomyositis2
Pemphigoid, Bullous2
Purpura2
Autoimmune Diseases1
Blood Coagulation Disorders1
Blood Platelet Disorders1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.